News - Boehringer Ingelheim, Production


Popular Filters

FDA issues CRL on empagliflozin, noting manufacturing deficiencies

FDA issues CRL on empagliflozin, noting manufacturing deficiencies


There was disappointment today for US drug major Eli Lilly and family-owned German pharma firm Boehringer…

Boehringer IngelheimDiabetesEli LillyempagliflozinNorth AmericaPharmaceuticalProductionRegulationUSA

Boehringer’s US injectables to cease production

Boehringer’s US injectables to cease production


Ben Venue Laboratories, a subsidiary of Boehringer Ingelheim, has decided to cease production by the…

Ben Venue LabsBoehringer IngelheimNorth AmericaPharmaceuticalProduction

SOBI gets FDA approval to manufacture substance for Kineret with partner Boehringer Ingelheim


Swedish Orphan Biovitrum (STO: SOBI) said today (June 11) that it has received approval from the US Food…

Boehringer IngelheimInflammatory diseasesKineretNorth AmericaPharmaceuticalProductionRegulationSavient PharmaceuticalsSwedish Orphan Biovitrum

Boehringer Ingelheim to build biopharma facility in China


German family-owned drug major Boehringer Ingelheim has signed a strategic alliance agreement and contract…

Asia-PacificBiotechnologyBoehringer IngelheimFinancialPharmaceuticalProductionShanghai Zhangjiang Biotech

Boehringer Ingelheim gets FDA warning letter on cGMP failures


German family-owned drug major Boehringer Ingelheim today (May 22) revealed that the US Food and Drug…

Boehringer IngelheimGenericsPharmaceuticalProductionRegulation

Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member


German family-owned drug major Boehringer Ingelheim said today (May 17) that it is updating health care…

Boehringer IngelheimCombivent RespimatManagementPharmaceuticalProductionRespiratory and Pulmonary

US federal judge approves consent decree with Boehringer's Ben Venue Labs


The US Food and Drug Administration announced today that a federal judge has approved a consent decree…

Ben Venue LabsBoehringer IngelheimGenericsLegalPharmaceuticalProductionRegulation

SOBI gains EMA approval for change of Kineret producer; Novartis drops NIC002 project


Swedish Orphan Biovitrum (STO: SOBI) has received approval from the European Medicines Agency for the…

BiotechnologyBoehringer IngelheimCytos BiotechnologyKineretLicensingNIC002NovartisPharmaceuticalProductionRegulationSwedish Orphan Biovitrum

Boehringer Ingelheim partners on DARPin molecules


German family-owned drug major Boehringer Ingelheim's biopharmaceutical contract manufacturing business…

Boehringer IngelheimDARPinMolecular PartnersPharmaceuticalProduction

Boehringer Ingelheim highlights robust respiratory R&D pipeline; announces investment


At its 3rd International Research & Development press conference, family-owned German drug major Boehringer…

afatinibBoehringer IngelheimnintedanibolodaterolOncologyPharmaceuticalProductionResearchRespimatRespiratory and Pulmonary

XOMA and Servier sign manufacturing deal with Boehringer for gevokizumab


US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) its partner France's Laboratoires Servier…

Boehringer IngelheimgevokizumabLicensingOphthalmicsPharmaceuticalProductionServierXOMA Corp

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top